For those of you that don’t want to blindly acce
Post# of 477
The latest PR is another example of a simple Outcome acting as a distraction to the FACT that FDA and the European Union both recognized Hemostyp as a safe and stable device for 8 years.
This same recognized product was used in Human trials and the results are a resounding success.
Yet in Thom’s 30 months he has been unable to convince European’s or the FDA that NEWLY manufactured and packaged USA products are not only safe, but are also identical to those used in human trials.
Like you, I refuse to pat him on his back for something that should have been completed minimum 18 months ago.
The fact that the new Hemostyp is SATISFACTORY should be expected at this stage. For readers to be excited, proves how low the expectations are of this team are.